Acquisition Opportunity Bio-Strategy is now part of DKSH Group, expanding its reach in Australia and New Zealand. This integration signals a broader distribution network for life sciences, medical and healthcare, and environment and agriculture sectors, presenting cross-sell potential for instrumentation, lab consumables, and assays.

Sustainability & Quality ISO 9001:2015 accreditation reinforces a quality-focused distribution model. Targeted sales opportunities exist in customers prioritizing validated supply chains, compliance-ready equipment, and reliable reagent sourcing for regulated research and clinical environments.

Storage & Automation Recent launch of Hamilton Storage tubes highlights a product line that supports automated workflows. This opens avenues to approach labs investing in high-throughput screening, sample handling efficiency, and reusable storage solutions.

Tech & Partner Ecosystem Utilization of AWS, Salesforce, OneTrust and other tech stack elements indicates modernized sales and compliance processes. Leverage these capabilities to offer streamlined procurement, data-enabled ordering, and secure vendor management for science institutions.

Revenue Growth Potential With revenue in the lower mid-range and a large geographic footprint post-acquisition, there is significant room to expand premier instrument and reagent sales, including niche life sciences, medical, and environmental testing solutions to new and existing customers.